Publications by authors named "Mayla Hsu"

Claim this Profile
E
Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020.
Allison DeLong, Mayla Hsu, Harriet Kotsoris

BMC Public Health· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.
Olga Mizenina, Mayla Hsu, Ninochka Jean-Pierre, Meropi Aravantinou, Keith Levendosky

Drug Deliv Transl Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques.
Mayla Hsu, Brandon F Keele, Meropi Aravantinou, Noa Krawczyk, Samantha Seidor

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge.
Mayla Hsu, Meropi Aravantinou, Radhika Menon, Samantha Seidor, Daniel Goldman

AIDS Res Hum Retroviruses· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.
Jessica Kenney, Meropi Aravantinou, Rachel Singer, Mayla Hsu, Aixa Rodriguez

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule inhibitor of hepatitis C virus entry.
Carl J Baldick, Michael J Wichroski, Annapurna Pendri, Ann W Walsh, Jie Fang, Mayla Hsu

PLoS Pathog· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.
Daniel J Tenney, Ronald E Rose, Carl J Baldick, Steven M Levine, Kevin A Pokornowski, Mayla Hsu

Antimicrob Agents Chemother· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entecavir resistance is rare in nucleoside naïve patients with hepatitis B.
Richard J Colonno, Ronald Rose, Carl J Baldick, Steven Levine, Kevin Pokornowski, Mayla Hsu

Hepatology· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques.
Mayla Hsu, Siu-Hong Ho, Peter Balfe, Agegnehu Gettie, Janet Harouse

J Acquir Immune Defic Syndr· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques.
Peter Balfe, Sarah Shapiro, Mayla Hsu, Clarisa Buckner, Janet M Harouse

Virology· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.
Mayla Hsu, Jie Zhang, Mike Flint, Carine Logvinoff, Cecilia Cheng-Mayer

Proc Natl Acad Sci U S A· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
Mayla Hsu, Janet M Harouse, Agegnehu Gettie, Clarisa Buckner, James Blanchard

J Virol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.
James Lue, Mayla Hsu, David Yang, Preston Marx, Zhiwei Chen

J Virol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis